Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

The Global Probiotics Market Forecasted to Flourish as Wellness Trends Gain Momentum, the Market to Hit $115.07 Billion?- Focus Research Report by Arizton


CHICAGO, April 9, 2024 /PRNewswire/ -- According to Arizton's latest focus insight report, the probiotics market is growing at a CAGR of 8.39% during 2023-2029.? 

Global Probiotics Market - Focused Insights 2024-2029

To Know More, Download the Free Sample Report: https://www.focusreports.store/report/probiotics-market-focused-insights

Probiotics Market Report Scope

Report Attributes???? 

Details????? 

Market Size (2029)???? 

USD 115.07 Billion? 

Market Size (2023)???? 

USD 70.95 Billion? 

CAGR (2023-2029)???? 

8.39 %

Historic Year??? 

2020-2022?? 

Base Year??? 

2023

Forecast Year???? 

2024-2029???? 

 

North America has the largest market share in the global probiotics market (2023). In 2023, the functional food and beverage segment accounted for a 83.06% share of the global probiotics market. The segment is anticipated to retain its market dominance during the forecast period. Customers have shown interest in purchasing probiotic-based functional foods, which will drive the market during the forecast period. The functional food & beverage segment is sub-segmented into dairy-based probiotics and non-dairy-based probiotics. Dairy-based probiotics include milk-based, yogurt-based, cheese-based, and others. Non-dairy-based probiotics include vegetable-based probiotics, fruit-based probiotics, cereal-based probiotics, and meat-based probiotics. Various diseases are increasing due to multiple reasons, such as unhealthy food consumption, changing lifestyles, and others. Many occur due to disturbed gut health. Thus, consumers prefer healthy foods & beverages that help to maintain gut health. They focus on offering foods with probiotics along with other nutrients. Therefore, the demand for functional food & beverage products will increase during the forecast period.
In 2023, the drug store segment accounted for a 15.29% share, with chain pharmacies experiencing rapid growth thanks to robust supply chains. Arizton forecasts an incremental growth of more than $6 billion, marking a substantial  absolute growth during the forecast period. These pharmacies, often situated near hospitals, serve as primary sources for medicines, including probiotics in various forms like tablets, powders, and capsules.

European countries are witnessing a surge in the proliferation of individual and chain pharmacies, with the latter benefiting from advantages in size and scale. This allows chain pharmacies to offer products at competitive prices compared to independent stores. Notable players in this domain include Walmart Stores, CVS Health Corporation, Walgreens Boots Alliances, McKesson Europe, Phoenix Group, and Penta Investments, operating across developed countries.

The COVID-19 pandemic further fueled the demand for pharmaceutical products, expanding the number of drug stores in developed nations.

Product Segmentation and Forecast

Vendors List

Key Questions Answered in the Report:
What factors are driving the global probiotics market?
What is the projected value of the global probiotics market by 2029?
Which segment leads the product type category in the probiotics market?
Which regions are significant players in the probiotics market?

Table of Content

CHAPTER ? 1: Probiotics Market Overview

CHAPTER ? 2: Probiotics Market

CHAPTER ? 3: Probiotics Market Segmentation Data

CHAPTER ? 4: Key Regions Overview

CHAPTER ? 5: Probiotics Market Prospects & Opportunities

CHAPTER ? 6: Probiotics Industry Overview

CHAPTER ? 7: Appendix

About Focused Reports by Arizton???? 

Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.? 

About Us:????????????????????????????????????????????????????????? 

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.??????????????????????????????????????????????????????? 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.???????????????????????????????????????????????????????? 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.???? 

Contact Us:????
Call: +1-312-235-2040??????????????????????????????????????????????? 
????????? +1 302 469 0707?????????????????????????????????????????????? 
Mail: [email protected]???
Website: https://www.focusreports.store/

Photo: https://mma.prnewswire.com/media/2382485/GLOBAL_PROBIOTICS_MARKET.jpg
Logo: https://mma.prnewswire.com/media/2326840/4638616/Focus_Reports_Logo.jpg

Focus_Reports_Logo

These press releases may also interest you

at 07:20
RS Oncology, a clinical-stage biopharmaceutical company focused on developing novel treatments for aggressive and rare cancers, today announced that it will present the complete Phase 1 dose escalation data as an oral presentation at the world's...

at 07:20
Merck , known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-811 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with trastuzumab and fluoropyrimidine- and...

at 07:10
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...

at 07:10
AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in San Diego, CA from May 17 - 22, 2024. The...

at 07:05
Natera, Inc. , a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of a new cfDNA-based fetal RhD test. This comes at a critical time for the healthcare industry, helping physicians navigate patient care given...

at 07:05
Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the California Institute for...



News published on and distributed by: